Clara Tam

Clara Tam

Auto-generated profile, based on publicly available information

Clara Tam

SPOR Evidence Alliance, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, East Building, Toronto, Ontario M5B1T8, Canada

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in HIV Medicine
Verified
Journal Article
Open access
EFEmma Finlayson-Trick
Emma Finlayson-Trick
CTClara Tam
Clara Tam
LWLu Wang
Lu Wang
NDNicole Dawydiuk
Nicole Dawydiuk
KSKate Salters
Kate Salters
DMDavid M. Moore
David M. Moore
Introduction: The COVID‐19 pandemic has changed healthcare service delivery. We examined the overall impact of COVID‐19 on people living with HIV in British Columbia (BC), Canada, with a special focus on the potential impact of COVID‐19 on antiretroviral treatment interruptions (TIs).Methods: Purposive sampling was used to enrol people living with HIV aged ≥19 years across BC into the STOP HIV/AIDS Program Evaluation study between January 2016 and September 2018. Participants completed surveys at baseline enrolment and 18 and 36 months later. Additional COVID‐19 questions were added to the survey in October 2020. TIs were defined as >60 days late for antiretroviral therapy (ART) refill using data from the BC HIV Drug Treatment Program. Generalized linear mixed models were used to examine trends in TIs over time and associations with reported health service access.Results: Of 581 participants, 6.1%–7.7% experienced a TI during each 6‐month period between March 2019 and August 2021. The frequency of TIs did not statistically increase during the COVID‐19 epidemic. Among the 188 participants who completed the COVID‐19 questionnaire, 32.8% reported difficulty accessing healthcare during COVID‐19, 9.7% reported avoiding continuing a healthcare service due to COVID‐19‐related concerns, and 74.6% reported using virtual healthcare services since March 2020. In multivariable analysis, the odds of a TI in any 6‐month period were not significantly different from March to August 2019. None of the reported challenges to healthcare services were associated with TIs.Conclusions: Although some participants reported challenges to accessing services or avoidance of services due to COVID‐19, TIs were not more likely during COVID‐19 than before.

25 February 2025 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
WZWasifa Zarin
Wasifa Zarin
SSSharmila Sreetharan
Sharmila Sreetharan
ADAmanda Doherty-Kirby
Amanda Doherty-Kirby
MSMichael Scott
Michael Scott
EZElaine Zibrowski
Elaine Zibrowski
ATAndrea C. Tricco
Andrea C. Tricco
To describe the Strategy for Patient-Oriented Research Evidence Alliance's methodological approach to systematically identify 23 high priority health research topics (three in 2021 and 20 in 2023) from patient partners (including caregivers) and members of the public across Canada and beyond. In 2021 and 2023, we collaborated with patient and public partners to co-design and co-conduct two priority setting initiatives. These initiatives involved a diverse group of patients, the public, clinicians, researchers, and health system decision-makers to systematically and collectively prioritize research topics based on their perceived importance and anticipated impact. We used a modified James Lind Alliance approach, where all participants were engaged as equal partners. The prioritization process consisted of the following steps: 1) identification and collection of research priorities from patients and the public; 2) summarizing the research priorities gathered; 3) conducting semistructured interviews (1-on-1 or focus groups depending on the number of submissions for each unique topic), conducting literature searches on each topic to identify relevant knowledge synthesis and appraising the quality of relevant evidence using the AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) checklist, and preparing lay summaries (1-2 pages) for each unique topic using a predefined template cocreated with patient partners; 4) conducting a priority setting exercise with a multidisciplinary panel consisting of an interim priority setting rating questionnaire to score each topic based on nine questions, followed by a virtual workshop to reach consensus on the final rating and ranking of topics; and 5) facilitating research by funding selected topics and providing capacity-building support to research teams. We conducted a formal process evaluation of engagement, transparency, information management, and considerations of values and context in 2023. A total of 98 topics were received across two research priority setting initiatives. Approximately, half the submissions were made by individuals who identified as patients (2021: 45% [n = 5] and 2023: 52% [n = 45]), whereas the rest identified as caregivers or members of the public. Topics were spread across 26 health themes, with arthritis and osteoporosis (27% [n = 3]) being the most common theme in 2021 and quality of care (26% [n = 23]) in 2023. Twenty-three priorities from 98 topics submitted by patients and public were selected. A formal process evaluation in 2023 revealed 85% of the respondents who participated in the priority setting panel "strongly agreed" that their experience was valuable and they would participate again in a future initiative. The 23 prioritized projects are currently being co-led with the patient and public partner topic submitters and nominated research teams. Priority setting exercises successfully engaged a diverse group of interested parties, resulting in the identification of relevant and impactful research topics. The positive feedback from participants suggests that these exercises were well-received and that similar methodologies should be applied and refined in future efforts. The Strategy for Patient-Oriented Research Evidence Alliance used a patient- and public-driven approach to set research priorities across different topics. They conducted two priority setting initiatives in 2021 and 2023, involving patients, the public, researchers, clinicians, and health system managers. This approach aimed to prioritize research topics based on their perceived importance and anticipated impact. A total of 98 topics were received across two research priority setting initiatives, with nearly half the submissions from patients and the other half from caregivers or members of the public. The topics covered 26 health themes, with arthritis and osteoporosis (2021) and quality of care (2023) being the most common themes. From these topics, the 23 highest priority topics were selected by a multidisciplinary priority setting panel. A formal process evaluation in 2023 revealed that 85% of the respondents who participated in the priority setting panel "strongly agreed" that their experience was valuable, and they would participate again in a future initiative. In conclusion, the priority setting exercises successfully engaged a diverse group of individuals and identified important research topics. The positive feedback suggests that this approach was well received and should be applied in future efforts.

14 November 2023 in AIDS Care
Verified
Journal Article
Closed access
CTClara Tam
Clara Tam
LWLu Wang
Lu Wang
KSKate Salters
Kate Salters
DMDavid Moore
David Moore
TWTim Wesseling
Tim Wesseling
RBRolando Barrios
Rolando Barrios
There is mixed evidence on whether experiences of HIV-related stigma are mitigated with lived experience. We sought to examine whether people living with HIV (PLWH) with longer living experience reported varying levels of HIV-related stigma. Between January 2016-September 2018, we used purposive sampling to enrol PLWH aged >= 19 across British Columbia, Canada, where participants completed the 10-item Berger HIV Stigma Scale. We conducted bivariate analyzes examining key sociodemographic characteristics and HIV-related stigma scores. Multivariable linear regression modelled the association between year of HIV diagnosis by treatment era and HIV-related stigma scores. We enrolled 644 participants; median age at enrolment was 50 years (Q1-Q3: 42-56), with 37.4% (n = 241) diagnosed before the year 2000. The median HIV-stigma scores of all participants (19.0, Q1-Q3: 13-25, range 0-40) stratified by treatment era were: 17.0 (pre-1996), 20.0 (1996-1999), 20.0 (2000-2009), 19.0 (2010-2018) (p = 0.03). While there was a significant association at the univariate level, year of HIV diagnosis by treatment era was not associated with stigma scores after controlling for age, gender, HIV key populations, ethnicity, relationship status, social support, and ever having a mental health disorder diagnosis. This suggests that PLWH still experience HIV-related stigma today, compared to those diagnosed in earlier time periods.